The cAMP-dependent protein kinase (PKA)/cAMP signaling pathway is an important target for T2D therapy development because of its central role in glucose homeostasis, including insulin and glucagon secretion, glycogen synthesis and breakdown, and gluconeogenesis (9). Here, INS is linked to type 2 diabetes mellitus.